UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
February 3, 2022
Jackson
Financial Inc.
(Exact name of registrant as specified in its
charter)
| Delaware |
|
001-40274 |
|
98-0486152 |
(State or other jurisdiction of incorporation or
organization) |
|
(Commission
File
Number) |
|
(I.R.S.
Employer Identification No.) |
1 Corporate Way, Lansing,
Michigan |
|
48951 |
| (Address of principal executive offices) |
|
(Zip Code) |
(517) 381-5500
(Registrant's telephone number, including area
code)
N/A
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material
pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
| Title of Each Class |
Trading Symbol(s) |
Name of Exchange on Which Registered |
| Class A Common Stock, Par Value $0.01 Per Share |
JXN |
New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (240.12b-2 of this chapter).
Emerging growth company ¨
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. ¨
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
As previously reported, Aimee DeCamillo, who was Executive Vice President
and Chief Commercial Officer of the Company and President of Jackson National Life Distributors, departed the Company. The Company’s
subsidiary, Jackson National Life Insurance Company, has entered into an agreement, effective February 3, 2022, regarding Ms. DeCamillo’s
separation from the Company. The agreement provides for (i) an aggregate cash payment to Ms. DeCamillo of $9,800,000, of which
$8,800,000 is payable within 30 days and the remaining $1,000,000 is payable on or before June 12, 2022, and (ii) a prorated
portion of performance share units and restricted stock units that were awarded prior to Ms. DeCamillo’s departure under the
Jackson Financial Inc. 2021 Omnibus Incentive Plan. The agreement also contains provisions regarding, among other things, confidential
information, non-solicitation, non-competition and a release.
Item
9.01. Financial
Statements and Exhibits.
(d) Exhibits.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| By: | /s/
Marcia Wadsten |
| | | Marcia Wadsten |
| | | Executive Vice President and Chief Financial Officer (Principal
Financial Officer) |
Date:
February 9, 2022
